Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01871805 |
|---|---|
| Brief Title: | A Study of Alectinib (CH5424802/RO5424802) in Participants With Anaplastic Lymphoma Kinase (ALK)-Rearranged Non-Small Cell Lung Cancer (NSCLC) |
| First Submitted : | May 28, 2013 |
| First Submitted that Met QC Criteria : | June 4, 2013 |
| First Posted : | June 7, 2013 (Estimate) |
| Results First Submitted : | January 14, 2016 |
| Results First Submitted that Met QC Criteria : | January 14, 2016 |
| Results First Posted : | February 12, 2016 (Estimate) |
| Last Update Submitted that Met QC Criteria : | July 23, 2018 |
| Last Update Posted : | August 21, 2018 |